Business
Vanda Pharmaceuticals hisseleri FDA’nın hareket hastalığı ilacını onaylamasıyla yükseldi
SOURCE:Investing Türkiye|BY:Investing.com
Failed to fetch content: Request failed with error code 403
Failed to fetch content: Request failed with error code 403